Physician profile
Candace Brooke Locklear
NPI 1043993959
$8,445.44
in general payments reported to CMS, 2019-2025
11 companies · $8,393 in 2025
The $8,393 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.48 · 2024: $34.95 · 2025: $8,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,644 · Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,644.08 |
| Food and Beverage | $801.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $7,664.31 | 2025 | |
| Abbvie INC. | $313.94 | 2025 | |
| Medicure Pharma INC. | $190.13 | 2025 | Zypitamag |
| Novo Nordisk INC | $89.72 | 2025 | Wegovy |
| Coloplast Corp | $82.01 | 2025 | |
| Exact Sciences Corporation | $19.91 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $18.93 | 2024 | Mounjaro |
| Janssen Pharmaceuticals, INC | $17.48 | 2023 | Xarelto |
| Pfizer INC. | $16.94 | 2025 | |
| Cranial Technologies, INC | $16.05 | 2025 | Doc Band |
| Organon LLC | $16.02 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Locklear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.